Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
Volume 355, Issues 1–2, 17 August 1996, Pages 253-261
Research paperMonitoring of occupational exposure to cytostatic anticancer agents
References (56)
- et al.
The effect of various antioxidants and other modifying agents on oxygen-radical generated DNA damage in human lymphocytes in the COMET assay
Mutation Res.
(1994) - et al.
Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
Mutation Res.
(1995) - et al.
Ras oncoproteins in human plasma from lung cancer patients and healthy controls
Mutation Res.
(1996) - et al.
Levels of ras oncoproteins in human plasma from 1,3-butadiene exposed workers and controls
Mutation Res.
(1996) Assessment of cytogenetic changes in human populations at risk in Eygpt
Mutation Res.
(1994)- et al.
Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs
Mutation Res.
(1985) - et al.
Molecular analysis of mutation at the hprt-locus of Chinese hamster V79 cells induced by ethyl-methanesulphonate and mitomycin C
Mutation Res.
(1993) - et al.
Mutagenicity in urine of nurses handling cytostatic drugs
Lancet
(1979) - et al.
DNA damage in nurses handling anti-neoplastic agents
Mutation Res.
(1995) - et al.
Occupational exposure to cyclophosphamide
Lancet
(1984)
Airborne drug levels in a laminar flow hood
Am. J. Hosp. Pharm.
(1981)
DNA protein cross-links and sister chromatid exchanges frequencies in lymphocytes and hydroxyethylmercapturic acid in urine of ethylene oxide-exposed hospital workers
Int. Arch. Occup. Environ. Health
(1994)
Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil
J. Occup. Med.
(1994)
Induction of sister chromatid exchanges among nurses handling cytostatic drugs
Assessment of potential exposure to anti-neoplastic agents in the health care setting
Prev. Med.
(1984)
Precautions followed by personnel involved with the preparation of parenteral anti-neoplastic medications
Hosp. Pharm.
(1980)
Bacterial mutagenicity assay in monitoring exposure to mutagens and carcinogens
The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment
Cancer Res.
(1988)
Microgel electrophoresis assay (COMET test) and SCE analysis in human lymphocytes from 100 normal subjects
Mutation Res.
(1994)
The potassium iodide method for determining protection factors in open-fronted microbiological safety cabinets
J. Appl. Biol.
(1981)
Mutation frequency in nurses and pharmacists working with cytotoxic drugs
Aust. NZ J. Med.
(1984)
Exposure of hospital workers to airborne anti-neoplastic agents
Am. J. Hosp. Pharm.
(1983)
Occupational health and staff monitoring: a genetic toxicologists viewpoint
J. Oncol. Pharm. Practice
(1995)
CIS-Diaminedichloroplatinum (II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of CIS-diaminedichloroplatinum (II)
Cancer Res.
(1987)
Cancer morbidity among Danish female pharmacy technicians
Scand. J. Work Environ. Health
(1994)
Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs and other potential hazards in hospitals based on registered information of outcome
J. Epidemiol. Commun. Health
(1985)
Cited by (0)
Copyright © 1996 Published by Elsevier B.V.